Form 4: Disc Medicine CEO Exercises Stock Options, Increasing Holdings
SEC Form 4 Filing
John D. Quisel, CEO of Disc Medicine, Inc., exercised stock options on April 7, 2025, acquiring 7,000 shares of common stock at $1.01 per share.
Summary
- On April 7, 2025, John D. Quisel, the CEO of Disc Medicine, Inc. (IRON), exercised stock options.
- This transaction involved the acquisition of 7,000 shares of common stock at a price of $1.01 per share.
- Following this transaction, Quisel directly owns 161,828 shares of common stock.
- Quisel also holds options for 208,420 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment. The document simply reports a transaction. The CEO exercising options could be seen as a positive, but it's a routine event.
Positives
- The CEO's decision to exercise stock options could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence from the CEO.
Key Dates
| Date | Description |
|---|---|
| 03/10/2030 | Expiration date of the stock options. |
| 04/07/2025 | Date of the transaction: CEO exercised stock options. |
| 04/08/2025 | Date of the signature on the Form 4 filing. |
Keywords
Disc Medicine, IRON, John D. Quisel, stock options, Form 4, insider trading, beneficial ownership, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.